Photocatalytic degradation of carbamazepine (CBZ) was investigated by hydrothermally synthesized antimony trioxide (Sb 2 O 3 )/lead oxide (PbO) photocatalyst. The photocatalyst synthesized with different ratio of Sb 2 O 3 and PbO viz. 1:1, 2:1, 3:1, 1:2, and 1:3. Photocatalyst with 3:1 ratio of Sb 2 O 3 and PbO showed the best photocatalytic activity towards CBZ. Transmission electron microscopy (TEM) analysis suggested that the particle size increased by increasing PbO ratio in the catalyst. It was observed that Sb 2 O 3 synthesis with PbO showed less band gap energy in comparison to Sb 2 O 3 . The Brunauer–Emmer–Teller (BET) surface area of the Sb 2 O 3 /PbO (3:1) was determined to be 4.78 m 2 g −1 . In absence of catalyst, very low degradation of CBZ was achieved, while significant enhancement in CBZ degradation was observed in presence of the synthesized catalyst. CBZ degradation followed the pseudo first-order kinetics with rate constant of 0.016 min −1 . Increased degradation rate was recorded when peroxymonosulfate (PMS) was used with UV/Sb 2 O 3 /PbO. Active species trapping experiment revealed that in CBZ degradation, O 2 – radical produced by synthesized catalysts played a major role. In presence of PMS, generation of S O 4 - ∙ radical enhanced the catalytic activity of synthesized catalyst.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: